B. Larsson et al., Extracts of ECL-cell granules/vesicles and of isolated ECL cells from rat oxyntic mucosa evoke a Ca2+ second messenger response in osteoblastic cells, REGUL PEPT, 97(2-3), 2001, pp. 153-161
Surgical removal of the acid-producing part of the stomach (oxyntic mucosa)
reduces bone mass through mechanisms not yet fully understood. The existen
ce of an osteotropic hormone produced by the so-called ECL cells has been s
uggested. These cells, which are numerous in the oxyntic mucosa, operate un
der the control of circulating gastrin. Both gastrin and an extract of the
oxyntic mucosa decrease blood calcium and stimulate Ca2+ uptake into bone.
Conceivably, gastrin lowers blood calcium indirectly by releasing a hypothe
tical hormone from the ECL cells. The present study investigated, by means
of fura-2 fluorometry, the effect of extracts of preparations enriched in E
CL cell granules/vesicles from rat oxyntic mucosa on mobilization of intrac
ellular Ca2+ in three osteoblast-like cell lines, UMR-106.01, MC3T3-E1 and
Saos-2, and of extracts of isolated ECL cells in UMR-106.01 cells. The extr
acts were found to induce a dose-related rapid increase in intracellular Ca
2+ concentrations in the osteoblast-like cells. The response was not due to
histamine or pancreastatin, known ECL cell constituents, and could be abol
ished by pre-digesting the extracts with exo-aminopeptidase. The results sh
ow that the increase in [Ca2+](i) reflects a mobilization of Ca2+ from the
endoplasmic reticulum. The observation of an increase in [Ca2+](i) also in
murine embryonic fibroblasts show that the response is not limited to osteo
blastic cells. The finding that the extracts evoked a typical Ca2+-mediated
second messenger response in osteoblastic cells provides evidence for the
existence of a novel osteotropic peptide hormone (gastrocalcin), produced i
n the ECL cells, and supports the view that gastrectomy-induced osteopathy
may reflect a lack of this hormone. (C) 2001 Elsevier Science B.V. All righ
ts reserved.